Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%) Dr Reddys Laboratories informs about company updates
Date: 09-03-2017Dr Reddys Laboratories has informed that the audit of Company’s formulation manufacturing facilty at Duwada, Visakhapatnam, by the US FDA, has been completed on March 08, 2017. The Company have been issued a Form 483 with 13 observations, which the Company is addressing.
The above information is a part of company’s filings submitted to BSE.